Testing effectiveness (Phase 2)Study completedNCT00378482
What this trial is testing
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.
Who this might be right for
Colorectal NeoplasmsMelanomaProstatic Neoplasms+3 more
AstraZeneca 37